AMRX — AMNEAL PHARMACEUTICALS INC

Ownership history in WINTON GROUP Ltd  ·  6 quarters on record

This page tracks every 13F SEC filing in which WINTON GROUP Ltd reported a position in AMNEAL PHARMACEUTICALS INC (AMRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2023 Q3)
Avg. % of fund
0.01%
First filed
2019 Q4
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 30,415 -21,507 -41.4% 0.01% $304K $10.01
2023 Q3 ADDED 51,922 +32,854 +172.3% 0.02% $219K $4.22
2023 Q2 ADDED 19,068 +5,576 +41.3% 0.00% $59K $3.10
2021 Q2 REDUCED 13,492 -18,578 -57.9% 0.00% $69K $5.12
2020 Q3 ADDED 32,070 +9,341 +41.1% 0.00% $124K $3.88
2019 Q4 INITIATED 22,729 — — 0.00% $110K $4.82
% of Fund (quarterly)    AMRX price (monthly, adj. close)

Other funds also holding AMRX

As of 2025 Q4 — sorted by position size

TPG GP A, LLC 3Y 5.78% Westshore Wealth, LLC 3Y 5.76% Phocas Financial Corp. 3Y 7Y 2.15% Rubric Capital Management LP 3Y 7Y 1.86% PFM Health Sciences, LP 3Y 7Y 1.84% BlackBarn Capital Partners LP 1.3% Nantahala Capital Management, LLC 3Y 7Y 1.02% Penn Capital Management Company, LLC 3Y 7Y 1.01% Jackson Creek Investment Advisors LLC 3Y 0.83% Informed Momentum Co LLC 3Y 7Y 0.6%
← Back to WINTON GROUP Ltd Holdings